CGON
CG Oncology, Inc.
Company Overview
| Mkt Cap | $3.33B | Price | $43.27 |
| Volume | 1.42M | Change | +1.88% |
| P/E Ratio | -37.9 | Open | $42.31 |
| Revenue | $1.1M | Prev Close | $42.47 |
| Net Income | $-88.0M | 52W Range | $14.80 - $45.56 |
| Div Yield | N/A | Target | $68.08 |
| Overall | 65 | Value | 55 |
| Quality | -- | Technical | 75 |
No chart data available
Stock Overview
Updated DailyCG Oncology, Inc. (CGON) is a leading diversified company in the business industry, currently trading at $43.27 with a market capitalization of $3.33 billion. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows CGON with a volume of 1.42 million shares. The stock opened down 0.38% from yesterday's close of $42.47. Current analyst estimates project earnings of $-2.15 per share for this year, with next year targeting $-2.67.
CGON demonstrates strong technical indicators based on technical analysis. The company trades on the NGS exchange.
Key investment considerations for CGON include solid overall investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 57.3%. The stock shows neutral valuation indicators based on valuation analysis.
Analysis generated on November 2, 2025 at 06:36 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CGON | $43.27 | +1.9% | 1.42M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |